Grifols, S.A.
Grifols, S.A. (GIFLF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GIFLF · as of Jun 9, 2026
Key Statistics
Explore Grifols, S.A. Data
giflf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 57.1%
Competitors & Peers
giflf competitorsGIFLF
BDUUF
CSPCY
ESAIY
ESALF
KYKOFStock Performance
Full HistoryAbout Grifols, S.A.
Grifols, S.A. a company established in Barcelona, Spain, in 1940, specializes in the sourcing, production, and sale of therapeutic products, principally derived from blood plasma. Its diverse activit…
what is grifols, s.a. · giflf stock overview · grifols, s.a. company profile · who is grifols, s.a. ceo · giflf OTC · grifols, s.a. headquarters · grifols, s.a. business segments
About Stock Overview & Key Data
Grifols, S.A. (GIFLF) is a Healthcare company in the Drug Manufacturers - General industry, listed on OTC since Jun 24, 2008. As of the latest trading session, GIFLF stock price is $11.12, with a market capitalization of $7.6B. The stock has returned +1.55% over the past 12 months and -4.63% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Grifols, S.A. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Grifols, S.A. reported revenue of $7.5B and net income of $401.7M. For detailed data — including Grifols, S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Grifols, S.A. (GIFLF) stock price is $11.12. The stock is traded on OTC under the ticker symbol GIFLF. The 52-week range is $10.57 – $14.00.